OBLYTECH Logo
OBLYTECH Logo
ServiceNow Audit Management for Life Sciences and Pharma
Home / Guides, Services and Solutions / by Industry / for Life Sciences and Pharma / ServiceNow Audit Management for Life Sciences and Pharma

ServiceNow Audit Management for Life Sciences and Pharma

Audit management for life sciences and pharma is the planning, execution and closure of internal audits and inspection readiness reviews across manufacturing, quality, data integrity and supplier controls. The aim is to find non-compliance before a regulator does, and to show that each finding led to a corrective action that worked.

How Life Sciences and Pharma Use Audit Management

An audit programme in a pharmaceutical or life sciences company has to serve three audiences at once: internal audits of manufacturing, quality systems, data integrity and suppliers; inspections by the FDA and European authorities; and the corrective actions that follow both. The sections below cover programme development and scheduling, execution and findings, corrective action tracking, regulatory readiness and trend analysis, then the working routine: choosing audit scope from a risk ranking of processes, running one audit from notice to closure, writing findings that survive a response, reading the trend across audit cycles, and when an audit is the wrong tool yet.

Audit Program Development and Scheduling

Pharmaceutical organisations develop comprehensive audit programs covering all aspects of their operations: manufacturing processes, quality systems, supplier management, data integrity, environmental controls, personnel training, and regulatory compliance. Audit programs specify the frequency of audits for each area based on risk: high-risk areas are audited frequently, lower-risk areas less frequently. Audit Management systems help schedule audits, coordinate with relevant departments, and track audit completion status. A well-designed audit program provides continuous monitoring of compliance and quality across the organisation.

Audit Execution and Finding Identification

Audits are conducted by qualified auditors who assess compliance with procedures, regulations, and quality standards. During audits, auditors interview personnel, review documentation, observe operations, and identify findings: instances of non-compliance or procedures not being followed as designed. Audit Management systems document findings clearly, assign severity ratings based on impact, and create action items for remediation. Findings are communicated to relevant departments for response and correction.

Corrective Action and Remediation Tracking

When audit findings are identified, departments responsible for the area audited develop corrective actions to address the findings and prevent recurrence. Corrective actions must address root causes, not just symptoms. Audit Management systems track corrective actions from inception through completion, verify that actions are effective, and confirm that the underlying issue has been resolved. Close-out of findings is documented, providing evidence that audit findings have been addressed.

Regulatory Readiness

When regulators conduct inspections, they often review audit reports and findings to assess whether the organisation has effective quality systems. Having a reliable audit program with documented audit findings and corrective actions demonstrates to regulators that the organisation takes quality seriously and has systems to identify and correct issues. Audit Management systems provide quick access to audit documentation, making it easy to respond to regulator inquiries or demonstrate compliance during inspections.

Continuous Improvement Through Audit Insights

Audit trends provide valuable insights into system effectiveness and areas needing improvement. If certain areas repeatedly have findings, that suggests systemic issues requiring attention: inadequate training, unclear procedures, or inadequate controls. Audit data can be analysed to identify patterns and prioritise improvements. Organisations that use audit data effectively for continuous improvement demonstrate progressively improving compliance and quality over time.

Audit Trends and Systemic Insights

Audit data collected over time reveals trends and systemic insights. If certain areas repeatedly have findings, that suggests systemic issues requiring root cause analysis and systemic solutions. Organisations can use audit trend analysis to prioritise improvement efforts where they will have greatest impact. Leading pharmaceutical organisations use audit insights proactively to improve quality systems before issues become widespread or result in regulatory violations.

Training and Audit Competency

Effective auditing requires competent auditors: people who understand quality systems, manufacturing processes, and regulatory requirements. Audit training programs develop auditor competencies in planning audits, conducting interviews, evaluating evidence, and documenting findings. Regular auditor training ensures that audit quality remains high and that auditors stay current with regulatory expectations. Audit Management systems can track auditor training and certifications, ensuring that only qualified auditors conduct audits. Over time, organisations with well-trained auditors produce higher-quality audit findings and recommendations.

Post-Inspection Follow-up

After inspection findings are communicated, organisations should prepare responses and remediation plans. Timelines for remediation depend on severity and risk: critical findings require rapid response, less critical findings may have longer remediation timelines. Organisations should track remediation progress and communicate updates to regulators or auditors. When remediation is complete, final verification that issues are resolved provides closure. Strong post-inspection follow-up demonstrates to regulators that organisations take compliance seriously.

Choosing audit scope from a risk ranking of processes

An audit program for a manufacturing or laboratory site should start from a list of processes ranked by what happens if they fail. A sterile filling line, a release testing step and a supplier that supplies an active ingredient carry different consequences from a training record for a support team. Rank each process on likelihood of failure and on harm if it does, then let the ranking decide which areas are audited, how deep the sampling goes and how often the area comes back. The ranking is a judgment the quality lead should be able to explain. It is not a score that needs to look scientific. A site that already keeps a register of process risks can reuse it.

Audit type Usual trigger Question it answers What a good output looks like
Scheduled internal audit The area’s place in the risk ranking Are the written procedures still followed as written? Findings tied to a named procedure clause and a record reviewed
For-cause audit A deviation cluster, complaint or failed test What failed, and was the failure isolated or systemic? A root cause statement that the area owner accepts
Supplier audit Qualification, requalification or a material change Does the supplier’s quality system meet the agreed requirements? A qualification decision with the evidence behind it
Readiness review An announced or likely regulatory inspection Could the site show its records and explain them quickly? A short list of gaps with owners and dates set by the site

Running one audit from notice to closure

  1. Write the audit objective and scope in one paragraph, naming the procedures, systems and time window the auditor will sample.
  2. Send the area owner the scope and the records to be pulled, so the evidence is ready rather than assembled during the visit.
  3. Carry out fieldwork by observing the task, reviewing the record and interviewing the person who does the work, and note where those three accounts disagree.
  4. Draft each finding with the requirement, the evidence seen, the consequence and the location, before any severity is assigned.
  5. Hold a closing meeting in which the area owner can correct facts. Disputed facts are recorded as disputed, not removed.
  6. Agree a response per finding, link it to a corrective action with an owner, and close the audit only when the effectiveness check has been done.

Writing findings that survive a response

A finding that says training is inadequate invites argument and often does not lead to a fix. A finding that says the operator signed the in-process check for a step whose training record did not cover the current procedure revision can be checked and corrected. Keep each finding to one requirement and one piece of evidence. Where several findings share a cause, record the shared cause as its own item so the response can address it once instead of five times. In an audit management application the finding should carry these parts as structured fields, so the corrective action links to it directly. Severity should describe the consequence to product, patient or data, and it should be set after the facts are agreed, because a severity argued before the facts are settled can be argued again later.

Where audit programs often go wrong

  • Every area is audited on the same cycle, so the highest-consequence processes get no more attention than a low-risk office function.
  • Findings are closed when the paperwork is filed, not when the behavior has changed, and the same finding can return at the next visit.
  • The audit team writes findings that the area owner first hears about in the report, which can make disputes slow and bitter.
  • Audit records sit in a spreadsheet beside the corrective action system, so it is hard to see that a finding has an open action. The evidence trail that holds these links together is described in this look at audit trail evidence.

Reading the trend across audit cycles

Look at three things over time rather than the raw count of findings. The first is repeat findings in the same area, because a falling number often means the cause has been addressed. The second is the share of findings that the area’s own self-inspection had already identified, since a rising share shows the site is learning to see its own gaps. The third is the age of open actions by severity. None of these is a target to set in isolation. Each should be read against the risk ranking, so that a rise in findings from a new process is not mistaken for decline. Ownership of each area’s risks, which decides who answers for a repeat finding, is covered in risk management accountability.

When an audit is the wrong tool yet

An audit tests whether a defined process is followed. If the process has never been written down, or has changed twice in the past quarter, an audit can produce findings about a moving target. In that case a walkthrough or a gap assessment is more useful: it documents how the work is actually done, identifies what needs a procedure, and sets the baseline the audit will test later. Where the gap assessment feeds a control framework, the governance, risk and compliance page for this industry covers the control side.

Questions about audit management that come up in practice

Should auditors be independent of the area they audit?

Independence is the common expectation for the formal program. An auditor from the same team can still observe and record facts, but the decision to close a finding should sit with someone outside that line.

How much of an audit should be sampled rather than read in full?

Sampling is set by the risk ranking and the volume of records. The sampling rule should be written in the audit plan before fieldwork begins, so the auditor cannot choose records that look better or worse after the fact.

What if the area owner disagrees with a finding?

Record the disagreement next to the finding with the evidence each side relies on. Escalate to the quality head if the dispute affects severity. Removing a finding because the owner objects is a documentation failure in its own right.

Can audit findings from a supplier feed the internal program?

Yes. A recurring supplier finding about a material specification may point to a gap in incoming inspection or in the specification itself, and it should be linked to the receiving process as well as to the supplier file. Life-sciences specific guidance on these records is collected on the life sciences and pharma industry hub.

Frequently asked questions

How frequently should we audit different areas of our operation?

Risk-based auditing is standard in pharma. High-risk areas (manufacturing, quality control, data integrity) are audited frequently (annually or more often). Lower-risk areas (administrative functions) may be audited less frequently, on a cycle set by the risk assessment.

What should we do if an audit finds a serious compliance violation?

Immediately assess the impact on product quality and regulatory compliance. Report to management and to regulatory authorities if required by regulations. Develop rapid corrective actions to address the issue and prevent recurrence. Implement enhanced monitoring until the issue is resolved.

How do we verify that corrective actions have actually fixed problems?

Follow-up audits or inspections of the area verify that corrective actions have been implemented and are effective. Root cause analysis ensures that actions address the underlying cause, not just symptoms. Monitoring metrics track whether issues have resolved and not recurred.

Talk to Oblytech

Planning, running or fixing a ServiceNow programme? Tell us where you are and we will suggest a sensible next step.

Contact us